Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members
Dentsply Sirona (XRAY) has appointed two new members to its Board of Directors: Michael J. Barber and Daniel T. Scavilla, effective February 5, 2025. Barber, with over 40 years of experience in product management and innovation at GE, will join the Science and Technology Committee. Scavilla, currently CEO of Globus Medical, will serve on the Audit and Finance Committee.
The appointments come as Dr. Dorothea Wenzel steps down from the board due to increased demands from her recently announced chair nomination. With these changes, the board size increases from 10 to 11 members. Over the past two years, the company has added four new board members as part of its ongoing board refresh strategy to support its transformation in dentistry.
Dentsply Sirona (XRAY) ha nominato due nuovi membri nel suo Consiglio di Amministrazione: Michael J. Barber e Daniel T. Scavilla, con effetto dal 5 febbraio 2025. Barber, con oltre 40 anni di esperienza nella gestione dei prodotti e nell'innovazione presso GE, entrerà a far parte del Comitato per la Scienza e la Tecnologia. Scavilla, attuale CEO di Globus Medical, servirà nel Comitato di Controllo e Finanza.
Queste nomine arrivano mentre la Dott.ssa Dorothea Wenzel si dimette dal consiglio a causa delle crescenti richieste legate alla sua recente nomina come presidente. Con queste modifiche, la dimensione del consiglio passerà da 10 a 11 membri. Negli ultimi due anni, l'azienda ha aggiunto quattro nuovi membri del consiglio come parte della sua continua strategia di rinnovamento del consiglio per supportare la sua trasformazione nel settore odontoiatrico.
Dentsply Sirona (XRAY) ha nombrado a dos nuevos miembros de su Junta Directiva: Michael J. Barber y Daniel T. Scavilla, con efecto a partir del 5 de febrero de 2025. Barber, con más de 40 años de experiencia en gestión de productos e innovación en GE, se unirá al Comité de Ciencia y Tecnología. Scavilla, actual CEO de Globus Medical, formará parte del Comité de Auditoría y Finanzas.
Los nombramientos se producen cuando la Dra. Dorothea Wenzel se retira de la junta debido a las crecientes demandas de su reciente nominación como presidenta. Con estos cambios, el tamaño de la junta aumenta de 10 a 11 miembros. En los últimos dos años, la empresa ha añadido cuatro nuevos miembros a la junta como parte de su estrategia continua de renovación para apoyar su transformación en el ámbito dental.
Dentsply Sirona (XRAY)는 Michael J. Barber와 Daniel T. Scavilla를 이사로 새롭게 임명했다고 발표했다. 이들은 2025년 2월 5일부터 임기가 시작된다. Barber는 GE에서 제품 관리와 혁신에 40년 이상의 경력을 가지고 있으며, 과학 및 기술 위원회에 합류할 예정이다. Scavilla는 현재 Globus Medical의 CEO로 재직 중이며, 감사 및 재무 위원회에서 활동할 것이다.
이번 임명은 Dorothea Wenzel 박사가 최근 발표된 의장 후보 제안으로 인해 이사회에서 물러나게 되면서 이루어졌다. 이로 인해 이사회의 구성원이 10명에서 11명으로 증가하게 된다. 지난 2년 동안 회사는 치과 분야의 변화를 지원하기 위해 지속적인 이사회 갱신 전략의 일환으로 새로운 이사 4명을 추가했다.
Dentsply Sirona (XRAY) a nommé deux nouveaux membres à son Conseil d'Administration : Michael J. Barber et Daniel T. Scavilla, à compter du 5 février 2025. Barber, fort de plus de 40 ans d'expérience en gestion de produits et innovation chez GE, rejoindra le Comité de la Science et de la Technologie. Scavilla, actuellement PDG de Globus Medical, siégera au Comité d'Audit et de Finances.
Ces nominations interviennent alors que Dr. Dorothea Wenzel se retire du conseil en raison des exigences accrues liées à sa récente nomination comme présidente. Avec ces changements, le conseil passe de 10 à 11 membres. Au cours des deux dernières années, l'entreprise a ajouté quatre nouveaux membres du conseil dans le cadre de sa stratégie de renouvellement continu pour soutenir sa transformation dans le domaine dentaire.
Dentsply Sirona (XRAY) hat zwei neue Mitglieder in den Aufsichtsrat berufen: Michael J. Barber und Daniel T. Scavilla, mit Wirkung zum 5. Februar 2025. Barber bringt über 40 Jahre Erfahrung im Produktmanagement und in der Innovation bei GE mit und wird dem Wissenschafts- und Technologiekomitee beitreten. Scavilla, der derzeit CEO von Globus Medical ist, wird im Audit- und Finanzausschuss tätig sein.
Die Ernennungen erfolgen, da Dr. Dorothea Wenzel aufgrund steigender Anforderungen aus ihrer jüngsten Nominierung als Vorsitzende aus dem Aufsichtsrat ausscheidet. Mit diesen Veränderungen vergrößert sich die Anzahl der Mitglieder im Aufsichtsrat von 10 auf 11. In den letzten zwei Jahren hat das Unternehmen vier neue Mitglieder in den Aufsichtsrat aufgenommen, um seine fortlaufende Erneuerungsstrategie zur Unterstützung der Transformation im zahnärztlichen Bereich zu unterstützen.
- Addition of two experienced executives with relevant industry expertise
- Board expansion demonstrates commitment to strategic transformation
- Enhanced board expertise in innovation, technology, finance, and operations
- Loss of experienced board member Dr. Wenzel
CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the “Board”), effective February 5, 2025.
Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company’s digital X-Ray program. Mr. Scavilla, currently CEO of Globus Medical, is a seasoned executive with a deep skillset in commercial deployment and business integration, having successfully led the merger of Globus and NuVasive. Mr. Barber will be joining the Board’s Science and Technology Committee and Mr. Scavilla will be joining the Board’s Audit and Finance Committee.
“We are pleased to welcome Mike and Dan, two proven leaders with skillsets that are additive to the expertise already represented on our Board and that will be extremely valuable as we continue to execute our transformation strategy,” said Greg Lucier, Chairman of the Board. “The Board regularly reviews our composition against our strategic priorities, and we believe that adding broad healthcare experience, as well as deep innovation, technology, finance and operational capabilities, will help Dentsply Sirona realize our vision of transforming dentistry to improve oral health globally as the industry continues to evolve. As we move forward, the Board will continue to actively and regularly evaluate all opportunities to drive durable, profitable growth and enhanced shareholder value.”
Mr. Barber said, “With Dentsply Sirona’s long heritage of innovation leadership in the global dental industry, I recognize the Company’s tremendous potential, and I am eager to contribute to advance its mission. I appreciate the Board’s confidence and look forward to working collaboratively with the rest of the Board and the management team to capitalize on the many opportunities ahead.”
Mr. Scavilla said, “I am honored to join the Board and continue to drive forward Dentsply Sirona’s mission of transforming and advancing innovation. As a longtime executive in the healthcare industry, I look forward to bringing my insights and experience to support the Company’s strategic growth.”
The Company also announced today that Dr. Dorothea Wenzel has informed the Board of her decision to resign, effective February 5, 2025, due to the increased demands of her recently announced chair nomination.
“On behalf of the Board and management team, I want to thank Dorothea for her contributions to our Company,” Mr. Lucier said. “The Board has benefitted greatly from her expertise and guidance, and we appreciate all she has done to help position Dentsply Sirona for the future.”
Dr. Wenzel added, “It has been an honor to serve on the Board over the last few years. I’m confident in the Board and management team’s ability to deliver on the Company’s strategy and drive long-term growth and profitability.”
With these changes, the Board has increased in size from 10 to 11 members. In the last two years, the Board has added four highly qualified members and will continue to refresh the Board to ensure the requisite skills to support the transformation of dentistry.
About Michael Barber
Mr. Barber has over 40 years of experience in executive positions with General Electric (NYSE: GE), featuring roles within operations, human capital, engineering, strategy, product management, and international P&L leadership. He has successfully launched transformational technologies and products to the market in the fields of diagnostic imaging and point-of-care technology. Mr. Barber also serves on the Board of Directors of Exact Sciences, Inc. (Nasdaq: EXAS) and as a member of the Executive Committee of the Green Bay Packers Football Club and the Board of Regents at the Milwaukee School of Engineering. He previously served on the Board of Directors of Catalent, Inc. He holds both a Bachelor of Science and an Honorary Doctorate in Electrical Engineering from the Milwaukee School of Engineering. He is a Member of the National Academy of Engineering (NAE) and a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).
About Daniel Scavilla
Mr. Scavilla has served as President and Chief Executive Officer of Globus Medical, Inc. (NYSE: GMED) since April 2022, leading Globus Medical’s acquisition of NuVasive, Inc. and integrating the two organizations to create the second largest spine technology company in the world. Prior to that, Mr. Scavilla held various executive leadership positions at the company, including serving as its Chief Financial Officer. Prior to joining Globus Medical, Mr. Scavilla spent 28 years in increasing leadership roles within Johnson & Johnson, including roles across different businesses. Mr. Scavilla serves on Globus Medical’s Board of Directors, and he previously served on the Board of Directors of Impulse Dynamics, a privately held medical technology company. Mr. Scavilla received a Bachelor of Science in Finance and Organizational Behavior from LaSalle University and a Master of Business Administration in International Management from Temple University.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality, and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Andrea Daley
Vice President, Investor Relations
+1-704-591-8631
InvestorRelations@dentsplysirona.com
Press:
Marion Par-Weixlberger
Vice President, Public Relations & Corporate Communications
+43 676 848414588
marion.par-weixlberger@dentsplysirona.com
FAQ
Who are the new board members appointed to Dentsply Sirona (XRAY) in February 2025?
What committees will the new XRAY board members serve on?
How many members are now on Dentsply Sirona's (XRAY) board after the February 2025 changes?
Why did Dr. Dorothea Wenzel resign from Dentsply Sirona's (XRAY) board?
How many new board members has XRAY added in the past two years?
